this post was submitted on 01 May 2025
6 points (100.0% liked)

Futurology

2562 readers
132 users here now

founded 2 years ago
MODERATORS
voidx
Lugh
Espiritdescali
AwesomeLowlander
6
HuidaGene Therapeutics used CRISPR gene-editing (Cas13) to modify genes in the brain for the first time, successfully treating a 9-year-old with MECP2 duplication syndrome. (archive.ph)
submitted 1 week ago by Lugh to c/futurology
1 comments fedilink hide all child comments
top 1 comments
sorted by: hot top controversial new old
[–] Lugh 4 points 1 week ago

This is a tentative result, it's only one patient, and large scale trials would be needed to confirm it. Still, if it is confirmed it's a significant breakthrough. HuidaGene is also working on treatments for Huntington's Disease, Duchenne muscular dystrophy (DMD among other diseases. It's also working on various Ophthalmology related conditions.